AI Democratizes Congenital Heart Disease Echo 03/30/26

Welcome to Cardiology Today – Recorded March 30, 2026. This episode summarizes 5 key cardiology studies on topics like Cardiovascular Disease and Imaging. Key takeaway: AI Democratizes Congenital Heart Disease Echo. Article Links: Article 1: Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study. (Circulation) Article 2: Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and Men. (Circulation) Article 3: Automated Echocardiographic Detection of Congenital Heart Disease Using Artificial Intelligence. (Circulation) Article 4: Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases. (European heart journal) Article 5: Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/ai-democratizes-congenital-heart-disease-echo-03-30-26/ Featured Articles Article 1: Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41904795 Summary: Combined post- and pre-capillary pulmonary hypertension associated with heart failure with preserved ejection fraction is a condition carrying significant mortality for which no proven therapies exist. The phase two randomized CADENCE study evaluated sotatercept as a potential treatment, administered at 0.3 or 0.7 milligrams per kilogram, or placebo, every three weeks. The primary endpoint measured was the change in pulmonary vascular resistance at week twenty-four. Article 2: Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and Men. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41903131 Summary: Myocardial infarction with non-obstructive coronary arteries presents with various underlying causes, often including mimicking conditions, despite imaging recommendations to identify etiologies. This international, prospective study characterized the mechanisms of myocardial infarction with non-obstructive coronary arteries, analyzed predictors of imaging abnormalities, and explored sex differences. Article 3: Automated Echocardiographic Detection of Congenital Heart Disease Using Artificial Intelligence. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41902792 Summary: Delayed or missed diagnosis of congenital heart disease significantly contributes to pediatric mortality worldwide. Expert echocardiography interpretation, which is central to diagnosing and triaging congenital heart disease, represents a scarce and maldistributed global resource. This study developed EchoFocus-C. H. D., an artificial intelligence-enabled tool designed to democratize diagnostics and extend expert-level interpretation beyond large academic centers. Article 4: Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41905344 Summary: Vigorous physical activity is known to provide greater health benefits per unit time than moderate activity, yet the full spectrum of these benefits across chronic diseases and the relative importance of intensity versus volume remains unclear. A prospective population-based cohort study of 96408 participants examined associations between the proportion of vigorous physical activity relative to total physical activity volume and the incidence of multiple chronic disease outcomes. Article 5: Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41903523 Summary: Elevated lipoprotein(a) levels are an established risk factor for atherosclerotic cardiovascular disease, however, its association with venous thromboembolism remains unclear, with potential modification by sex and hormonal status. This study investigated this relationship using participants from the U. K. Biobank with baseline lipoprotein(a) data. The study design excluded individuals with a history of venous thromboembolism or cancer, as well as those using anticoagulants. Transcript Today’s date is March 30, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study. Combined post- and pre-capillary pulmonary hypertension associated with heart failure with preserved ejection fraction is a condition carrying significant mortality for which no proven therapies exist. The phase two randomized CADENCE study evaluated sotatercept as a potential treatment, administered at 0.3 or 0.7 milligrams per kilogram, or placebo, every three weeks. The primary endpoint measured was the change in pulmonary vascular resistance at week twenty-four. Article number two. Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and Men. Myocardial infarction with non-obstructive coronary arteries presents with various underlying causes, often including mimicking conditions, despite imaging recommendations to identify etiologies. This international, prospective study characterized the mechanisms of myocardial infarction with non-obstructive coronary arteries, analyzed predictors of imaging abnormalities, and explored sex differences. Article number three. Automated Echocardiographic Detection of Congenital Heart Disease Using Artificial Intelligence. Delayed or missed diagnosis of congenital heart disease significantly contributes to pediatric mortality worldwide. Expert echocardiography interpretation, which is central to diagnosing and triaging congenital heart disease, represents a scarce and maldistributed global resource. This study developed EchoFocus-C. H. D., an artificial intelligence-enabled tool designed to democratize diagnostics and extend expert-level interpretation beyond large academic centers. Article number four. Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases. Vigorous physical activity is known to provide greater health benefits per unit time than moderate activity, yet the full spectrum of these benefits across chronic diseases and the relative importance of intensity versus volume remains unclear. A prospective population-based cohort study of 96408 participants examined associations between the proportion of vigorous physical activity relative to total physical activity volume and the incidence of multiple chronic disease outcomes. Article number five. Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men. Elevated lipoprotein(a) levels are an established risk factor for atherosclerotic cardiovascular disease, however, its association with venous thromboembolism remains unclear, with potential modification by sex and hormonal status. This study investigated this relationship using participants from the U. K. Biobank with baseline lipoprotein(a) data. The study design excluded individuals with a history of venous thromboembolism or cancer, as well as those using anticoagulants. Thank you for listening. Don’t forget to subscribe. Keywords Cardiovascular Disease, Imaging, EchoFocus-C. H. D., Sotatercept, Pediatric Mortality, Artificial Intelligence, Atherosclerotic Cardiovascular Disease, Combined Post- and Pre-capillary Pulmonary Hypertension, Lipoprotein(a), Sex Differences, Physical Activity, Vigorous Physical Activity, Phase two trial, Physical Activity Intensity, Echocardiography, Physical Activity Volume, Congenital Heart Disease, Myocardial Infarction with Non-Obstructive Coronary Arteries, Hormonal Status, Chronic Diseases, Heart Failure with Preserved Ejection Fraction, Venous Thromboembolism, Predictors, Pulmonary Vascular Resistance, Etiologies. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post AI Democratizes Congenital Heart Disease Echo 03/30/26 first appeared on Cardiology Today.